- Report
- January 2026
- 128 Pages
Global
From €3562EUR$3,950USD£3,055GBP
- Report
- January 2026
- 140 Pages
Global
From €3562EUR$3,950USD£3,055GBP
- Report
- January 2026
- 149 Pages
Global
From €3562EUR$3,950USD£3,055GBP
- Report
- January 2026
- 149 Pages
Global
From €3562EUR$3,950USD£3,055GBP
- Report
- January 2026
- 153 Pages
Global
From €3562EUR$3,950USD£3,055GBP
- Report
- November 2025
- 147 Pages
Global
From €3562EUR$3,950USD£3,055GBP
- Report
- November 2025
- 140 Pages
Global
From €3562EUR$3,950USD£3,055GBP
- Report
- November 2025
- 145 Pages
Global
From €3562EUR$3,950USD£3,055GBP
- Report
- November 2025
- 147 Pages
Global
From €3562EUR$3,950USD£3,055GBP
- Report
- October 2025
- 151 Pages
Global
From €3562EUR$3,950USD£3,055GBP
- Report
- October 2025
- 148 Pages
Global
From €3562EUR$3,950USD£3,055GBP
- Report
- April 2026
- 167 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- March 2026
- 164 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- March 2026
- 245 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- February 2026
- 188 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- February 2026
- 172 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- February 2026
- 193 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- February 2026
- 190 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- February 2026
- 199 Pages
Global
From €4374EUR$4,850USD£3,751GBP
- Report
- February 2026
- 155 Pages
Global
From €4374EUR$4,850USD£3,751GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more